Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Nippon Chemiphar Sees Profits Halved
Sales Drop 4% Due To Japanese NHI Drug Price Revisions
Mar 20 2020
•
By
Akriti Seth
The firm’s declining sales and profits have led it to slash its forecasts • Source: Shutterstock
More from Earnings
More from Business